108 related articles for article (PubMed ID: 3235819)
1. The platelet serotonergic system in depression and following sertraline treatment.
Butler J; Leonard BE
Int Clin Psychopharmacol; 1988 Oct; 3(4):343-7. PubMed ID: 3235819
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
Phillips OM; Wood KM; Williams DC
Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
[TBL] [Abstract][Full Text] [Related]
3. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats.
Butler J; Tannian M; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):585-94. PubMed ID: 3222448
[TBL] [Abstract][Full Text] [Related]
4. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.
Sanders-Bush E; Breeding M; Knoth K; Tsutsumi M
Psychopharmacology (Berl); 1989; 99(1):64-9. PubMed ID: 2550988
[TBL] [Abstract][Full Text] [Related]
5. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
Bevan J; Heptinstall S
Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
[TBL] [Abstract][Full Text] [Related]
6. Sertraline: a new antidepressant.
Doogan DP; Caillard V
J Clin Psychiatry; 1988 Aug; 49 Suppl():46-51. PubMed ID: 2842321
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of sertraline: a review.
Heym J; Koe BK
J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
[TBL] [Abstract][Full Text] [Related]
8. Sertraline in coexisting major depression and diabetes mellitus.
Goodnick PJ; Kumar A; Henry JH; Buki VM; Goldberg RB
Psychopharmacol Bull; 1997; 33(2):261-4. PubMed ID: 9230640
[TBL] [Abstract][Full Text] [Related]
9. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
10. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
Koe BK; Koch SW; Lebel LA; Minor KW; Page MG
Eur J Pharmacol; 1987 Sep; 141(2):187-94. PubMed ID: 2824215
[TBL] [Abstract][Full Text] [Related]
11. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
12. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
[TBL] [Abstract][Full Text] [Related]
13. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
Sallee FR; Hilal R; Dougherty D; Beach K; Nesbitt L
J Am Acad Child Adolesc Psychiatry; 1998 Jul; 37(7):777-84. PubMed ID: 9666634
[TBL] [Abstract][Full Text] [Related]
15. High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline.
Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
Neurosci Lett; 2003 Jul; 345(2):105-8. PubMed ID: 12821182
[TBL] [Abstract][Full Text] [Related]
16. Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats.
Gill K; Amit Z; Koe BK
Alcohol; 1988; 5(5):349-54. PubMed ID: 3219181
[TBL] [Abstract][Full Text] [Related]
17. [3H] sertraline binding to rat brain membranes.
Koe BK; Lebel LA; Welch WM
Psychopharmacology (Berl); 1990; 100(4):470-6. PubMed ID: 2138796
[TBL] [Abstract][Full Text] [Related]
18. Human platelet 5HT receptors: characterisation and functional association.
Peters JR; Grahame-Smith DG
Eur J Pharmacol; 1980 Dec; 68(3):243-56. PubMed ID: 7202490
[TBL] [Abstract][Full Text] [Related]
19. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
[TBL] [Abstract][Full Text] [Related]
20. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Serebruany VL; Glassman AH; Malinin AI; Nemeroff CB; Musselman DL; van Zyl LT; Finkel MS; Krishnan KR; Gaffney M; Harrison W; Califf RM; O'Connor CM;
Circulation; 2003 Aug; 108(8):939-44. PubMed ID: 12912814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
